To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03023124
Title Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor (STRADA)
Acronym STRADA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Italian Sarcoma Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.